Form 4: SeaStar Medical Holding Corp: Director Acquires Shares

SeaStar Medical Holding Corp reports a transaction where Director Kenneth Van Heel acquired 4,000 restricted stock units.

Summary

• Director Kenneth Van Heel acquired 4,000 restricted stock units (RSUs) on July 1, 2026.
• These RSUs are scheduled to vest in full on July 1, 2027.
• Following this transaction, Mr. Van Heel beneficially owns 11,940 shares of common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as it represents a standard RSU award to a director, which is a common compensation practice rather than a significant market-moving event.

Positives

• Director acquisition of shares can signal confidence in the company's future prospects.
• The acquisition of 4,000 RSUs indicates a direct investment by a key insider.

Future Outlook

The RSUs awarded to Director Kenneth Van Heel will vest in full on July 1, 2027, indicating a future potential increase in his beneficial ownership.

Industry Context

StockSavvy.ai notes that insider transactions, such as this acquisition of restricted stock units by a director, are common in the biotechnology and medical device sectors as a form of long-term incentive and alignment with shareholder interests.

Stakeholder Impact

• Shareholders: The acquisition by a director may be viewed positively as a sign of commitment, but it does not represent new capital for the company.

Next Steps

• The restricted stock units will vest on July 1, 2027.

Key Dates

Keywords

SeaStar Medical Holding Corp, ICU, Form 4, Insider Transaction, Restricted Stock Units, Director, Securities Ownership